The NOVA2 gene helps nerve cells process RNA, the working copy of genetic instructions, so the brain can make and use proteins at the right time. If this gene does not work properly, brain development can be affected, which may lead to developmental delay, speech and learning differences, low muscle tone, or autism features. Its role is especially important in the developing nervous system. Pathogenic variants in the NOVA2 gene are an uncommon cause of a neurodevelopmental condition.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, the parts of cells that do much of the work. Others mainly direct when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they may influence how you respond to food, stress, and medications. For a closer look at this topic, you can learn more in the LearnHub.
Overview
NOVA2Gene function
What if the gene works
The NOVA2 gene helps nerve cells process RNA, a working copy of genetic instructions. This supports normal brain development and communication between nerve cells.
Risk
What if the gene does not work
Pathogenic variants in the NOVA2 gene are linked to a neurodevelopmental condition, often with delayed speech and learning, autistic features, and low muscle tone. Effects can range from milder to more severe, influencing when difficulties appear and their range.
Treatment
What does that mean for your treatment
No NOVA2-specific treatment or drug selection approach is currently established in clinical guidelines. Care is supportive and based on a person’s symptoms rather than the NOVA2 gene itself. Research is still early and is mainly exploring how the NOVA2 gene affects how nerve cells use genetic instructions, which may help guide future therapies.
Gene function
What if the gene works
In the brain and nervous system, the NOVA2 gene helps cells turn genetic instructions into the right working messages. Its protein mainly guides RNA processing, a step between DNA and protein making. This careful editing supports nerve cell development and everyday signaling.
The NOVA2 gene helps nerve cells edit RNA messages after DNA is copied. It decides which pieces are kept or skipped, so cells can make the right protein versions at the right time.
By shaping RNA messages, the NOVA2 gene supports how nerve cells grow, move, and connect. This helps the developing brain build organized networks for later communication.
Many RNA messages controlled by the NOVA2 gene are used at synapses, the contact points where nerve cells pass signals. This helps communication between neurons stay coordinated during day to day brain activity.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the NOVA2 gene make the protein shorter or less stable, so cells have less working NOVA2 or a version that binds RNA poorly. This helps explain how variants influence the NOVA2 gene's function, especially its control of RNA splicing (the editing step that helps cells assemble proteins correctly). Some changes leave partial activity, while more severe loss-of-function variants can disrupt this process more strongly and are often linked to more marked developmental effects.
How variants are linked to conditions
Pathogenic variants in the NOVA2 gene cause a rare neurodevelopmental condition, often described as NOVA2-related developmental delay with speech delay and autism-related features. Reported cases also include intellectual disability, low muscle tone, feeding difficulties, and movement differences in some people. Because this is a single-gene condition, a confirmed pathogenic NOVA2 variant can support or confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, one well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the NOVA2 gene. For many living with a harmful NOVA2 change, the condition is mainly driven by the gene change itself rather than lifestyle or everyday exposures, so the focus is usually on early support and monitoring.
Inheritance of NOVA2 variants
For families asking about the inheritance of the NOVA2 gene variants, the recognized pattern is autosomal dominant. This means one altered copy of the NOVA2 gene can be enough to cause a NOVA2-related condition, and an affected parent could pass it to a child with a 50% chance in each pregnancy. Many reported cases, though, have happened because of a new, de novo variant that was not inherited from either parent. When that is the case, brothers and sisters usually have a low chance of having the same variant, while an affected person may pass it on to their own children.
What does my NOVA2 result mean for my family?
For NOVA2, the known condition is usually linked to a change in just one copy of the gene, so close relatives such as parents, brothers, sisters, or children may also carry it. In many families, though, the NOVA2 change happened new in the affected child and was not inherited from either parent. That means the family impact can vary, and testing sometimes helps clarify whether others in the family are likely to have the same change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the NOVA2 gene, NOVA2 genetic testing uses a blood or saliva sample to read the gene’s DNA sequence. This is usually done as part of a broader panel, exome test (which reads many genes), or genome test (which reads nearly all DNA), and the lab compares your result with a reference sequence to identify and classify variants.
When should I consider getting a genetic test?
Consider genetic testing for the NOVA2 gene when a child has unexplained developmental delay, marked speech delay, learning problems, autism traits, or unusual findings on a brain scan. A test can help confirm whether a change in NOVA2 is the cause.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it can tell you depends on the condition and on the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information offers context more than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a medication more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, have less effect in another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how genetic differences affect responses to medications. It examines connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This understanding can support treatment decisions that are more informed and more personalized. To explore this subject further, you can learn more in the LearnHub.
Drugs influenced by the NOVA2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. For questions about side effects, treatment changes, or other health concerns, it is best to speak with your doctor.
History
Research on the NOVA2 gene grew out of work in the 1990s on rare neurologic syndromes linked to cancer, when scientists identified NOVA proteins as targets of the immune system in some affected people. That connection drew attention to a family of genes active in the nervous system, including the NOVA2 gene. Building on this early work, scientists mapped where these genes were located and studied how they were switched on in different tissues. As genetic methods improved, NOVA2 became part of a broader shift toward understanding brain development through gene activity rather than visible anatomy alone. In recent years, reports of people with rare NOVA2 variants have given the gene a clearer place in medical genetics. These studies helped move NOVA2 from a research finding to a gene with recognized clinical relevance.